Psycho-Oncology最新文献

{"title":"Mail-out bowel cancer screening: Identifying the behavioural stumbling blocks.","authors":"Larry Myers,&nbsp;Belinda C Goodwin,&nbsp;Michael Ireland,&nbsp;Sonja March,&nbsp;Joanne Aitken","doi":"10.1002/pon.5866","DOIUrl":"https://doi.org/10.1002/pon.5866","url":null,"abstract":"<p><strong>Objective: </strong>To describe the actions taken by recipients of mail-out faecal occult blood test (FOBT) kits and to identify the points at which progress towards kit completion typically stops. Differences according to gender, age, and screening intention were also examined.</p><p><strong>Methods: </strong>1599 people completed an online survey identifying the actions they took upon receiving an FOBT kit. Latent class analysis was conducted to identify latent subgroups of participants that reported similar actions. Differences between gender, age, and intention status were assessed using non-invariance testing.</p><p><strong>Results: </strong>Four latent subgroups of FOBT invitees were identified: those who complete and return their FOBT kit ('completers'); those who bring the kit into their house but go no further ('ignorers'); those who open the package and read the bowel cancer information materials but go no further ('readers'); and those who read the instructions but do not place the kit near the toilet and do not complete their FOBT kit ('leavers'). Non-completers who intended to use the kit were most likely to be in the 'leavers' class, while those who had no intention were most likely to be in the 'readers' class.</p><p><strong>Conclusions: </strong>Distinct subgroups of non-responders exist among bowel cancer screening invitees, suggesting different behaviour change interventions are needed to facilitate participation. Some invitees, especially those with high participatory intention, are likely to benefit from prompts to take the kit into the toilet, while others, with little participatory intention, often read the invitation materials presenting an opportunity to intervene with health messages.</p>","PeriodicalId":516935,"journal":{"name":"Psycho-Oncology","volume":" ","pages":"816-823"},"PeriodicalIF":3.6,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39885072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pilot randomized psychosocial trial of a screening intervention in pediatric oncology.","authors":"Maru Barrera,&nbsp;Leandra Desjardins,&nbsp;Soni Prasad,&nbsp;Wendy Shama,&nbsp;Sarah Alexander,&nbsp;Peter Szatmari,&nbsp;Kelly Hancock","doi":"10.1002/pon.5857","DOIUrl":"https://doi.org/10.1002/pon.5857","url":null,"abstract":"<p><strong>Objective: </strong>Psychosocial screening is a standard of care in pediatric oncology, but there is limited information about how to intervene after screening. This pilot trial aimed to determine feasibility of the novel Enhanced Psychosocial Screening Intervention (EPSI) and explore its preliminary efficacy outcomes. We examined rates of recruitment, retention, intervention acceptability, and monthly distress screening completion, as well as exploratory efficacy outcomes (Patient-Reported Outcomes Measurement Information System: depression, anxiety and fatigue; distress thermometer, pain and sleep).</p><p><strong>Methods: </strong>Parallel-group randomized pilot trial: Caregiver-youth (10-17 years at enrollment, newly diagnosed with cancer) dyads were randomly allocated to either EPSI or standard care with 1:1 ratio allocation. EPSI consists of having a Psychosocial Navigator who shares screening results conducted near diagnosis and monthly for one year with treating teams and families, and provides recommendations tailored to screening results.</p><p><strong>Results: </strong>Enrollment rate was 54% (38 dyads); retention was 90% and acceptability 86% (caregivers) and 76% (youth). Exploratory symptoms of depression, anxiety, distress and fatigue outcomes consistently improved mainly for caregivers.</p><p><strong>Conclusions: </strong>Results suggest EPSI is feasible and acceptable and exploratory mental and physical efficacy outcomes are promising for use in a future confirmatory multisite efficacy trial.</p>","PeriodicalId":516935,"journal":{"name":"Psycho-Oncology","volume":" ","pages":"735-744"},"PeriodicalIF":3.6,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39650811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Decreased mental health, quality of life, and utilization of professional help in cancer patients with unexpressed needs: A longitudinal analysis.","authors":"Verena Heß,&nbsp;Karin Meng,&nbsp;Thomas Schulte,&nbsp;Silke Neuderth,&nbsp;Jürgen Bengel,&nbsp;Hermann Faller,&nbsp;Michael Schuler","doi":"10.1002/pon.5856","DOIUrl":"https://doi.org/10.1002/pon.5856","url":null,"abstract":"<p><strong>Background: </strong>Cancer patients' mental health and quality of life can be improved through professional support according to their needs. In previous analyses of the UNSAID study, we showed that a relevant proportion of cancer patients did not express their needs during the admission interview of inpatient rehabilitation. We now examine trajectories of mental health, quality of life, and utilization of professional help in cancer patients with unexpressed needs.</p><p><strong>Methods: </strong>We enrolled 449 patients with breast, prostate, and colon cancer at beginning (T0) and end (T1) of a 3-week inpatient rehabilitation and 3 (T2) and 9 (T3) months after discharge. We explored depression (PHQ-2), anxiety (GAD-2), emotional functioning (EORTC QLQ-C30), fear of progression (FoP-Q-SF), and global quality of life (EORTC QLQ-C30) using structuring equation models. Furthermore, we evaluated self-reports about expressing needs and utilization of professional help at follow-up.</p><p><strong>Results: </strong>Patients with unexpressed needs (24.3%, n = 107) showed decreased mental health compared to other patients (e.g., depression: d T0 = 0.32, d T1-T3 = 0.39). They showed a significant decline in global quality of life at discharge and follow-up (d = 0.28). Furthermore, they had a higher need for support (Cramer's V T2 = 0.10, T3 = 0.15), talked less about their needs (Cramer's V T2 = 0.18), and made less use of different health care services at follow-up.</p><p><strong>Conclusion: </strong>Unexpressed needs in cancer patients may be a risk factor for decreased mental health, quality of life, and non-utilization of professional help in the long term. Further research should clarify causal relationships and focus on this specific group of patients to improve cancer care.</p>","PeriodicalId":516935,"journal":{"name":"Psycho-Oncology","volume":" ","pages":"725-734"},"PeriodicalIF":3.6,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39942045","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cognitive variables associated with depressive and anxiety symptoms in patients with cancer: A five-year follow-up study.","authors":"Amador Priede,&nbsp;Noelia Rodríguez-Pérez,&nbsp;Fernando Hoyuela,&nbsp;Patricia Cordero-Andrés,&nbsp;Olga Umaran-Alfageme,&nbsp;César González-Blanch","doi":"10.1002/pon.5864","DOIUrl":"https://doi.org/10.1002/pon.5864","url":null,"abstract":"<p><strong>Background: </strong>Patients with cancer are at increased risk of developing symptoms of depression and anxiety. However, data on the variables associated with these symptoms in the long term are scant. This study aims to evaluate rumination and thought suppression as explanatory variables of depressive and anxiety symptoms at one- and five-year follow-up in patients diagnosed with cancer.</p><p><strong>Methods: </strong>A total of 131 patients with cancer were assessed at baseline (≤4 months of diagnosis), and at 1 and 5 years after diagnosis. A battery of self-reported measures was used to evaluate anxiety and depressive symptoms, rumination, thought suppression, social support, and self-efficacy. The associations among these variables were assessed with linear mixed-effects models.</p><p><strong>Results: </strong>The models for depressive and anxiety symptoms explained 43.5% and 44.2% of the variance, respectively. Rumination was a significant explanatory variable of both depressive and anxiety symptoms over the five-year follow-up period, while thought suppression was only associated with anxiety symptoms. Female gender was associated with a higher risk of presenting anxiety symptoms but this same variable was also protective against depressive symptoms.</p><p><strong>Conclusions: </strong>The assessment and treatment of rumination and thought suppression in patients diagnosed with cancer is advisable, as these cognitive domains seem to be associated to symptoms of emotional disorders in the long term.</p>","PeriodicalId":516935,"journal":{"name":"Psycho-Oncology","volume":" ","pages":"798-805"},"PeriodicalIF":3.6,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39737163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Corrigendum: Risk perception, treatment adherence, and personality during COVID-19 pandemic: An international study on cancer patients.","authors":"Simone Cheli","doi":"10.1002/pon.5899","DOIUrl":"https://doi.org/10.1002/pon.5899","url":null,"abstract":"Pearson correlation Distress Risk perception Safe guard Non adherence Negative affect Detachment Antagonism Disinhibtion Psychotic Distress 1.00 0.35** −0.20** 0.28** 0.67** 0.54** 0.34** 0.32** 0.51** Risk perception 0.35** 1.00 −0.27** 0.20** 0.24** 0.12** −0.02 −0.06 0.08* Safe guard −0.20** −0.27** 1.00 −0.03 −0.19** −0.19** −0.06 −0.05 −0.15** Non adherence 0.28** 0.20** −0.03 1.00 0.17** 0.21** 0.10** 0.13** 0.14** Negative affect 0.67** 0.24** −0.19** 0.17** 1.00 0.53** 0.44** 0.48** 0.56** Detachment 0.54** 0.12** −0.19** 0.21** 0.53** 1.00 0.46** 0.45** 0.59** Antagonism 0.34** −0.02 −0.06 0.10** 0.44** 0.46** 1.00 0.47** 0.57** Disinhibtion 0.32** −0.06 −0.05 0.13** 0.48** 0.45** 0.47** 1.00 0.54** Psychotic 0.51** 0.08* −0.15** 0.14** 0.56** 0.59** 0.57** 0.54** 1.00","PeriodicalId":516935,"journal":{"name":"Psycho-Oncology","volume":" ","pages":"865-866"},"PeriodicalIF":3.6,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175543/pdf/PON-31-865.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39937310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Age-stratified distress thermometers with Worry and Learning problem domains for the paediatric oncology population: Development and validation.","authors":"Ray Cuffe,&nbsp;Catherine Norman,&nbsp;Gabriella Haeems,&nbsp;Lucy Spicer,&nbsp;Kabir Mohammed,&nbsp;Melanie Rodger,&nbsp;Lesley Edwards","doi":"10.1002/pon.5870","DOIUrl":"https://doi.org/10.1002/pon.5870","url":null,"abstract":"<p><strong>Background: </strong>The long-term psychological/neuro-psychological sequalae for a minority of survivors of childhood cancer are considerable. This project aims to develop and validate a psychosocial and memory/learning distress thermometer (DT) for paediatric/young adult cancer patients.</p><p><strong>Methods: </strong>Pilot/Development Age-appropriate versions of the DT were developed. A pilot study tested acceptability, usability, and design.</p><p><strong>Validation: </strong>Seven collaborating paediatric-oncology centres with 549 participants validated the DT against Strengths and difficulties questionnaire (SDQ) and Hospital Anxiety and depression scale (HADS) for psychological issues, Utilities Index Mark 2 (HUI2) for memory/learning issues, PedsQL and SF-8 measured quality of life.</p><p><strong>Results: </strong>Using a cut-off of four, sensitivity against SDQ for under 18 was 75.8%, 18plus against HADS was 94.1%. The specificity was 53.3% against the SDQ for the 18plus specificity against the HADS was 47.1%. The sensitivity against the HUI2 for all age groups was 89.0% specificity was 70.3%.</p><p><strong>Conclusion: </strong>The DT is a valid and reliable measure screening instrument. It can be used to identify early on those experiencing psychological distress and memory problems.</p>","PeriodicalId":516935,"journal":{"name":"Psycho-Oncology","volume":" ","pages":"832-839"},"PeriodicalIF":3.6,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39783777","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Exploring predictors of and barriers to online prostate cancer community use: A cross-sectional survey of users and non-users.","authors":"Denise Pyle,&nbsp;Gerry Tehan,&nbsp;Andrea Lamont-Mills,&nbsp;Suzanne K Chambers","doi":"10.1002/pon.5867","DOIUrl":"https://doi.org/10.1002/pon.5867","url":null,"abstract":"<p><strong>Objective: </strong>Prostate cancer survivors are increasingly turning to online communities for support. This study explored predictors of and barriers to use.</p><p><strong>Methods: </strong>A prospective survey of 141 Australian prostate cancer survivors assessed sociodemographic, clinical, psychosocial, and attitudinal characteristics associated with intention to use, and subsequent use of online communities.</p><p><strong>Results: </strong>The sample was divided into current, past, and non-user groups. Current users reported more intent to use online communities and had higher levels of social support. Current and past users, and their close contacts, held a more positive attitude towards use. Non-users experienced more barriers to use, fewer life impacts due to health changes, and were more likely to live in rural or remote regions. According to current users online prostate cancer communities are too informal, to past users they are too time intensive, and non-users believe they are too shallow. The most critical barriers to use were finding a suitable community, time to use them, and being capable of talking about or articulating their illness on the Internet. While these forums allow men to share experiences, gain recognition and understanding, and receive information, they may lead men to becoming too preoccupied with their illness and feeling more concerned about the consequences of their disease.</p><p><strong>Conclusion: </strong>Improving attitudes towards online communities and reducing barriers to use may help better encourage men with unmet supportive care needs to seek help from these groups. Future research exploring supporter attitudes towards use and explicating how men are supported online is needed.</p>","PeriodicalId":516935,"journal":{"name":"Psycho-Oncology","volume":" ","pages":"824-831"},"PeriodicalIF":3.6,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39772899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Exploring primary breast cancer survivors' self-management of sustained cancer-related cognitive impairment in the workplace.","authors":"Bethany Chapman,&nbsp;Nazanin Derakshan,&nbsp;Elizabeth A Grunfeld","doi":"10.1002/pon.5844","DOIUrl":"https://doi.org/10.1002/pon.5844","url":null,"abstract":"<p><strong>Objective: </strong>Work plays a central role in return to a more 'normal' life among women diagnosed with primary breast cancer. However, ongoing cancer-related cognitive impairment (CRCI) and cancer-related sequelae continue to detrimentally impact workability. Only a few studies have explored the long-term consequences of CRCI and self-management coping strategies applied in the workplace. This study explored women's experiences of sustained post-treatment CRCI and its impact on workability beyond the initial return-to-work (RTW), as well as experiences of self-management coping strategies.</p><p><strong>Method: </strong>Forty employed women with a diagnosis of primary breast cancer who were between 6 and 60 months post-active treatment completed a semi-structured telephone interview. A 'framework' analysis approach was used.</p><p><strong>Results: </strong>Two superordinate themes were identified: 'Sustained consequences of CRCI' and 'Self-management coping strategies to support work-related performance'. We found that the impact of CRCI extends beyond the initial RTW. The adopted self-management coping strategies could provoke mixed emotions, including emotional distress. Reduced workability was experienced up to 5-years post-active-treatment.</p><p><strong>Conclusion: </strong>Sustained CRCI induces negative emotions, fatigue and diminishes confidence reducing workability long into survivorship beyond RTW. The self-management coping strategies implemented to manage these sequelae generate mixed feelings, with some describing the strategies as problematic and of little benefit.</p>","PeriodicalId":516935,"journal":{"name":"Psycho-Oncology","volume":" ","pages":"606-613"},"PeriodicalIF":3.6,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39561852","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"'A fascinating time to be involved with research' exploring the impact of COVID-19 on postgraduate psycho-oncology researchers.","authors":"Lucy King,&nbsp;Sara Matthews,&nbsp;Claire Foster,&nbsp;Rachel Starkings,&nbsp;Patricia Holch,&nbsp;Kate Absolom,&nbsp;Stephanie Archer","doi":"10.1002/pon.5885","DOIUrl":"https://doi.org/10.1002/pon.5885","url":null,"abstract":"School of Social Sciences, Leeds Beckett University, Leeds, UK Faculty of Health and Life Sciences, Oxford Brookes University, Oxford, UK Macmillan Survivorship Research Group, Health Sciences, University of Southampton, Southampton, UK Sussex Health Outcomes Research & Education in Cancer (SHORE‐C), Brighton and Sussex Medical School, Brighton, UK Psychology Department, Leeds School of Social Sciences, Leeds Beckett University, Leeds, UK Patient Centred Outcome Research, Leeds Institute of Medical Research at St James’s, Leeds, UK Division of Health Services Research, Leeds Institute of Health Sciences, Leeds, UK Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK Department of Surgery and Cancer, Imperial College London, London, UK Department of Psychology, University of Cambridge, Cambridge, UK","PeriodicalId":516935,"journal":{"name":"Psycho-Oncology","volume":" ","pages":"671-675"},"PeriodicalIF":3.6,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39948851","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"What would I do? Perspectives on the factors underlying Lynch syndrome genetic testing and results sharing decisions for high-risk colorectal cancer patients.","authors":"Gabriella Tiernan,&nbsp;Victoria Freeman,&nbsp;April Morrow,&nbsp;Emily Hogden,&nbsp;Karen Canfell,&nbsp;Yoon-Jung Kang,&nbsp;Natalie Taylor","doi":"10.1002/pon.5840","DOIUrl":"https://doi.org/10.1002/pon.5840","url":null,"abstract":"<p><strong>Objective: </strong>Universal tumour testing for Lynch syndrome (LS) in all incident colorectal cancers (CRCs) and sequential diagnostic genetic testing is cost-effective in Australia. Because of this, our study aimed to understand factors underlying possible decisions faced by tumour test-positive CRC patients and their at-risk relatives throughout the LS diagnosis pathway.</p><p><strong>Methods: </strong>Semi-structured telephone interviews were conducted with 23 participants, using four hypothetical scenarios. Vignette-guided closed- and open-ended questions asked about LS genetic testing uptake, discussing diagnosis with at-risk relatives, and risk-reducing interventions. Personal perspectives on genetic testing were collected pre-post vignette discussion. Inductive thematic analysis was performed on open-ended questions. Decisional pathway diagrams were developed to convey factors influencing complex decision-making processes.</p><p><strong>Results: </strong>Participant responses incorporated unfolding scenario information, resulting in three decision themes: (1) wanting to know one's LS status; (2) informing family about LS; (3) navigating risk-reducing interventions. Across all themes, 'knowledge' emerged as a facilitator, and 'negative emotional experience' as a barrier. Personal supportive views toward genetic testing increased post-interview.</p><p><strong>Conclusions: </strong>When communicating with tumour test-positive CRC patients or their relatives about LS genetic testing, providing guidance/resources to inform decisions around risk-reducing interventions and informing family members is critical. Scenario-driven interviews provide insight into what individuals might do when facing complex healthcare decisions and could aid informed decision-making. This approach may be applicable in other conditions, particularly with mainstreaming being increasingly introduced into the genetic context.</p>","PeriodicalId":516935,"journal":{"name":"Psycho-Oncology","volume":" ","pages":"587-596"},"PeriodicalIF":3.6,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298871/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39558466","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}